Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adults
Clinical trial NCT05913973 · COMPLETED
Trial details
- NCT number
- NCT05913973
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-04
- Primary completion
- 2025-11-12
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.